Detalhe da pesquisa
1.
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.
Nature
; 608(7921): 199-208, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35859180
2.
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC).
Br J Cancer
; 130(1): 53-62, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37980367
3.
Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer.
Prostate
; 82 Suppl 1: S25-S36, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35657159
4.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35657158
5.
TP53 Alterations Are Associated With Poor Survival in Patients With Primary Mediastinal Nonseminoma Germ Cell Tumors.
Oncologist
; 27(11): e912-e915, 2022 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36166584
6.
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Cancer
; 127(12): 1965-1973, 2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33690902
7.
Olaparib for the treatment of metastatic prostate cancer.
Future Oncol
; 17(19): 2413-2429, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33769071
8.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Lancet Oncol
; 20(12): 1730-1739, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31727538
9.
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
Int J Cancer
; 145(12): 3453-3461, 2019 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31125117
10.
Biomarkers for Programmed Death-1 Inhibition in Prostate Cancer.
Oncologist
; 24(4): 444-448, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30541755
11.
DNA repair defects in prostate cancer: impact for screening, prognostication and treatment.
BJU Int
; 123(5): 769-776, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30281887
12.
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
J Pathol
; 246(2): 244-253, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30015382
13.
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
Bioinformatics
; 33(1): 26-34, 2017 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27531099
14.
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw
; 16(8): 933-937, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30099369
15.
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation.
Int J Mol Sci
; 17(9)2016 Sep 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27618023
16.
nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing.
Genome Res
; 22(11): 2250-61, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22745232
17.
ShatterProof: operational detection and quantification of chromothripsis.
BMC Bioinformatics
; 15: 78, 2014 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-24646301
18.
Molecular landscape of carcinoma invading bladder muscle: does patient age matter?
BJU Int
; 124(5): 719-721, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31074172
19.
In Brief: Chromothripsis and cancer.
J Pathol
; 231(1): 1-3, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23744564
20.
Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.
JCO Precis Oncol
; 8: e2300654, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38547422